Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican experts
Acute heart failure (HF) is associated with poor prognosis. After the acute event, there is a vulnerable period during which the patient has a marked risk of readmission or death. Therefore, early optimization of treatment is mandatory during the vulnerable period. The objective of this article is t...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioExcel Publishing Ltd
2024-01-01
|
| Series: | Drugs in Context |
| Subjects: | |
| Online Access: | https://www.drugsincontext.com/vulnerable-period-in-heart-failure-a-window-of-opportunity-for-the-optimization-of-treatment-a-statement-by-mexican-experts/ |
| _version_ | 1827380773849661440 |
|---|---|
| author | José Antonio Magaña Serrano José Angel Cigarroa López Adolfo Chávez Mendoza Juan Betuel Ivey-Miranda Genaro Hiram Mendoza Zavala Luis Olmos Domínguez Sergio Armando Chávez Leal José Ernesto Pombo Bartelt Eduardo Heberto Herrera-Garza Gerardo Mercado Leal Rodolfo Parra Michel Luisa Fernanda Aguilera Mora Patricia Lenny Nuriulu Escobar |
| author_facet | José Antonio Magaña Serrano José Angel Cigarroa López Adolfo Chávez Mendoza Juan Betuel Ivey-Miranda Genaro Hiram Mendoza Zavala Luis Olmos Domínguez Sergio Armando Chávez Leal José Ernesto Pombo Bartelt Eduardo Heberto Herrera-Garza Gerardo Mercado Leal Rodolfo Parra Michel Luisa Fernanda Aguilera Mora Patricia Lenny Nuriulu Escobar |
| author_sort | José Antonio Magaña Serrano |
| collection | DOAJ |
| description | Acute heart failure (HF) is associated with poor prognosis. After the acute event, there is a vulnerable period during which the patient has a marked risk of readmission or death. Therefore, early optimization of treatment is mandatory during the vulnerable period. The objective of this article is to provide recommendations to address the management of patients with HF during the vulnerable period from a practical point of view. A group of Mexican experts met to prepare a consensus document. The vulnerable period, with a duration of up to 6 months after the acute event – either hospitalization, visit to the emergency department or the outpatient clinic/day hospital – represents a real window of opportunity to improve outcomes for these patients. To best individualize the recommendations, the management strategies were divided into three periods (early, intermediate and late vulnerable period), including not only therapeutic options but also evaluation and education. Importantly, the recommendations are addressed to the entire cardiology team, including physicians and nurses, but also other specialists implicated in the management of these patients. In conclusion, this document represents an opportunity to improve the management of this population at high risk, with the aim of reducing the burden of HF. |
| first_indexed | 2024-03-08T13:40:07Z |
| format | Article |
| id | doaj.art-4781ec8d405645caba9c0ac11e3bb6ef |
| institution | Directory Open Access Journal |
| issn | 1740-4398 |
| language | English |
| last_indexed | 2024-03-08T13:40:07Z |
| publishDate | 2024-01-01 |
| publisher | BioExcel Publishing Ltd |
| record_format | Article |
| series | Drugs in Context |
| spelling | doaj.art-4781ec8d405645caba9c0ac11e3bb6ef2024-01-16T11:22:01ZengBioExcel Publishing LtdDrugs in Context1740-43982024-01-011311810.7573/dic.2023-8-1Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican expertsJosé Antonio Magaña SerranoJosé Angel Cigarroa LópezAdolfo Chávez MendozaJuan Betuel Ivey-MirandaGenaro Hiram Mendoza ZavalaLuis Olmos DomínguezSergio Armando Chávez LealJosé Ernesto Pombo BarteltEduardo Heberto Herrera-GarzaGerardo Mercado LealRodolfo Parra MichelLuisa Fernanda Aguilera MoraPatricia Lenny Nuriulu EscobarAcute heart failure (HF) is associated with poor prognosis. After the acute event, there is a vulnerable period during which the patient has a marked risk of readmission or death. Therefore, early optimization of treatment is mandatory during the vulnerable period. The objective of this article is to provide recommendations to address the management of patients with HF during the vulnerable period from a practical point of view. A group of Mexican experts met to prepare a consensus document. The vulnerable period, with a duration of up to 6 months after the acute event – either hospitalization, visit to the emergency department or the outpatient clinic/day hospital – represents a real window of opportunity to improve outcomes for these patients. To best individualize the recommendations, the management strategies were divided into three periods (early, intermediate and late vulnerable period), including not only therapeutic options but also evaluation and education. Importantly, the recommendations are addressed to the entire cardiology team, including physicians and nurses, but also other specialists implicated in the management of these patients. In conclusion, this document represents an opportunity to improve the management of this population at high risk, with the aim of reducing the burden of HF.https://www.drugsincontext.com/vulnerable-period-in-heart-failure-a-window-of-opportunity-for-the-optimization-of-treatment-a-statement-by-mexican-experts/acutedecompensationheart failuretreatmentvulnerable period |
| spellingShingle | José Antonio Magaña Serrano José Angel Cigarroa López Adolfo Chávez Mendoza Juan Betuel Ivey-Miranda Genaro Hiram Mendoza Zavala Luis Olmos Domínguez Sergio Armando Chávez Leal José Ernesto Pombo Bartelt Eduardo Heberto Herrera-Garza Gerardo Mercado Leal Rodolfo Parra Michel Luisa Fernanda Aguilera Mora Patricia Lenny Nuriulu Escobar Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican experts Drugs in Context acute decompensation heart failure treatment vulnerable period |
| title | Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican experts |
| title_full | Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican experts |
| title_fullStr | Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican experts |
| title_full_unstemmed | Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican experts |
| title_short | Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican experts |
| title_sort | vulnerable period in heart failure a window of opportunity for the optimization of treatment a statement by mexican experts |
| topic | acute decompensation heart failure treatment vulnerable period |
| url | https://www.drugsincontext.com/vulnerable-period-in-heart-failure-a-window-of-opportunity-for-the-optimization-of-treatment-a-statement-by-mexican-experts/ |
| work_keys_str_mv | AT joseantoniomaganaserrano vulnerableperiodinheartfailureawindowofopportunityfortheoptimizationoftreatmentastatementbymexicanexperts AT joseangelcigarroalopez vulnerableperiodinheartfailureawindowofopportunityfortheoptimizationoftreatmentastatementbymexicanexperts AT adolfochavezmendoza vulnerableperiodinheartfailureawindowofopportunityfortheoptimizationoftreatmentastatementbymexicanexperts AT juanbetueliveymiranda vulnerableperiodinheartfailureawindowofopportunityfortheoptimizationoftreatmentastatementbymexicanexperts AT genarohirammendozazavala vulnerableperiodinheartfailureawindowofopportunityfortheoptimizationoftreatmentastatementbymexicanexperts AT luisolmosdominguez vulnerableperiodinheartfailureawindowofopportunityfortheoptimizationoftreatmentastatementbymexicanexperts AT sergioarmandochavezleal vulnerableperiodinheartfailureawindowofopportunityfortheoptimizationoftreatmentastatementbymexicanexperts AT joseernestopombobartelt vulnerableperiodinheartfailureawindowofopportunityfortheoptimizationoftreatmentastatementbymexicanexperts AT eduardohebertoherreragarza vulnerableperiodinheartfailureawindowofopportunityfortheoptimizationoftreatmentastatementbymexicanexperts AT gerardomercadoleal vulnerableperiodinheartfailureawindowofopportunityfortheoptimizationoftreatmentastatementbymexicanexperts AT rodolfoparramichel vulnerableperiodinheartfailureawindowofopportunityfortheoptimizationoftreatmentastatementbymexicanexperts AT luisafernandaaguileramora vulnerableperiodinheartfailureawindowofopportunityfortheoptimizationoftreatmentastatementbymexicanexperts AT patricialennynuriuluescobar vulnerableperiodinheartfailureawindowofopportunityfortheoptimizationoftreatmentastatementbymexicanexperts |